Viewing Study NCT00961857


Ignite Creation Date: 2025-12-24 @ 6:55 PM
Ignite Modification Date: 2026-01-25 @ 6:48 AM
Study NCT ID: NCT00961857
Status: COMPLETED
Last Update Posted: 2019-11-13
First Post: 2009-08-18
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Demonstrate the Bioequivalence of Sitagliptin/Metformin Combination Tablets and Concomitant Administration of Sitagliptin and Metformin as Individual Tablets (0431A-048)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 2 Diabetes View
Keywords: